Search

Search Results
Results 1111 - 1120 of 1436 for Throat Cancer
  • Genetic clue found to Chronic Fatigue Syndrome
    News - 24 Apr 2006
    According to researchers from the Centers for Disease Control and Prevention (CDC), in the United States, there may well be a genetic reason why some people develop Chronic Fatigue Syndrome (CFS).
  • Severe Acute Respiratory Syndrome (SARS) overview
    News - 24 Apr 2004
    Severe Acute Respiratory Syndrome (SARS) is an atypical form of pneumonia that first appeared in November 2002 in Guangdong Province, China.
  • Votrient
    Drug - 4 Jun 2026
    Consumer Medicine Information (CMI) about Votrient intended for persons living in Australia.
  • Duoplidogrel
    Drug - 3 Jun 2026
    Consumer Medicine Information (CMI) about Duoplidogrel intended for persons living in Australia.
  • DuoCover
    Drug - 3 Jun 2026
    Consumer Medicine Information (CMI) about DuoCover intended for persons living in Australia.
  • Clopidogrel Winthrop Plus Aspirin
    Drug - 3 Jun 2026
    Consumer Medicine Information (CMI) about Clopidogrel Winthrop Plus Aspirin intended for persons living in Australia.
  • APX-Clopidogrel/Aspirin 75/100
    Drug - 3 Jun 2026
    Consumer Medicine Information (CMI) about APX-Clopidogrel/Aspirin 75/100 intended for persons living in Australia.
  • Duodart
    Drug - 26 May 2026
    Consumer Medicine Information (CMI) about Duodart intended for persons living in Australia.
  • Doubluts
    Drug - 26 May 2026
    Consumer Medicine Information (CMI) about Doubluts intended for persons living in Australia.
  • Avodart
    Drug - 26 May 2026
    Consumer Medicine Information (CMI) about Avodart intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback